Inside Drug Pricing

CSRxP: Latest Hike In Rx Drug Prices Shows Need For Congress To Act

By Luke Zarzecki / July 15, 2024 at 5:04 PM

The Campaign for Sustainable Rx Pricing (CSRxP) criticized pharmaceutical companies for raising prices on prescription drugs and called for lawmakers to continue to address high drug prices, pointing to data from Patients for Affordable Drugs showing brand-name drug companies upped the price tag on 195 prescription drugs between June 30 and July 5.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

CSRxP: Latest Hike In Rx Drug Prices Shows Need For Congress To Act

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.